Q2 2025 13F Holders as of 30 Jun 2025
-
Type / Class
-
Equity / Common Stock, $0.001 par value per share
-
Shares outstanding
-
53,599,048
-
Total 13F shares
-
56,749,470
-
Share change
-
+2,177,111
-
Total reported value
-
$4,754,316,405
-
Put/Call ratio
-
116%
-
Price per share
-
$83.78
-
Number of holders
-
231
-
Value change
-
+$213,454,333
-
Number of buys
-
155
-
Number of sells
-
91
Institutional Holders of SOLENO THERAPEUTICS INC - Common Stock, $0.001 par value per share (SLNO) as of Q2 2025
As of 30 Jun 2025,
SOLENO THERAPEUTICS INC - Common Stock, $0.001 par value per share (SLNO) was held by
231 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
56,749,470 shares.
The largest 10 holders included
JANUS HENDERSON GROUP PLC, Vivo Capital, LLC, ADAGE CAPITAL PARTNERS GP, L.L.C., PRICE T ROWE ASSOCIATES INC /MD/, FMR LLC, BlackRock, Inc., VANGUARD GROUP INC, Avoro Capital Advisors LLC, CITADEL ADVISORS LLC, and WESTFIELD CAPITAL MANAGEMENT CO LP.
This page lists
232
institutional shareholders reporting positions in this security
for the Q2 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.